Status:
COMPLETED
Obstructive Sleep Apnea Syndrome and Fibromiyalgia
Lead Sponsor:
Haydarpasa Numune Training and Research Hospital
Conditions:
Fibromyalgia, Primary
Eligibility:
All Genders
30-65 years
Brief Summary
-------------Obstructive sleep apnea syndrome (OSAS) is a syndrome characterized by recurrent complete (apnea) or partial (hypopnea) upper respiratory tract obstruction episodes during sleep and a dec...
Detailed Description
Patients between 30-65 years of age who were diagnosed with OSAS according to American Academy of Sleep Medicine (AASM) criteria and who had clinical symptoms of OSAS for at least 1 year before diagno...
Eligibility Criteria
Inclusion
- Being between the ages of 1-30-65
- Being diagnosed with Obstructive Sleep apnea syndrome and/or having CPAP treatment indication
Exclusion
- Chronic inflammatory or autoimmune disease
- hyperthyroidism/hyperthyroidism
- Cognitive dysfunction (such as dementia)
- Severe psychiatric disorder
- Antidepressant medication used in the last 2 weeks
- Non-steroid inflammatory drug used in the last 24 hours
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2019
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT06595771
Start Date
August 1 2018
End Date
February 1 2019
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haydarpaşa Numune Education and Research Hospital
Istanbul, Turkey (Türkiye)